Mauro Ferrari, Ph.D, is the Honorary President of the Accademia di Gagliato. He lives in Houston, Texas, where he is the President and CEO of the Houston Methodist Research Institute, and Executive Vice President of the Houston Methodist Hospital System. He is recognized as one of the founders of biomedical nano/micro technology, especially in its applications to drug delivery for cancer therapy (see latest discovery published on Nature Biotechnology on March 14, 2016). Dr. Ferrari is the author of more than 250 journal articles, 30 patents, and 6 books. He received countless honors and awards all over the world, and served in many national agencies, both in the USA and in Italy. He is a champion of ‘translational medicine’, that is, the process of bringing transformational new therapies from the laboratory to the clinic in the speediest (and safest) way.